查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1853713

治療性呼吸設備市場按設備類型、應用、最終用戶、分銷管道、技術、模式和患者類型分類－全球預測（2025-2032年）

Therapeutic Respiratory Devices Market by Device Type, Application, End User, Distribution Channel, Technology, Mode, Patient Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，治療性呼吸設備市場規模將達到 706 億美元，複合年成長率為 16.15%。

關鍵市場統計數據
基準年2024年 213億美元
預計年份：2025年 246.8億美元
預測年份 2032 706億美元
複合年成長率 (%) 16.15%

全面概述了不斷發展的呼吸護理設備市場格局以及產品、臨床和商業領導者的策略重點。

本執行摘要對呼吸治療設備進行了全面分析，探討了影響其研發、分銷和臨床應用的結構性、技術性和監管性因素。其目的是為高階領導、策略團隊和臨床採購相關人員提供清晰、基於證據的關鍵趨勢、競爭動態和營運考量，這些因素都會影響產品系列和服務線的決策。

我們首先將呼吸治療設備置於更廣泛的呼吸護理體系中，重點關注門診和家庭護理模式日益融合、數位化設備功能加速發展以及以患者為中心的設計理念的日益重視。這些進展共同凸顯了互操作系統、使用者友善介面和健全的上市後監測的重要性。在此背景下，領導者必須平衡臨床療效、成本控制和監管合規性的需求，同時預見支付方期望和醫療服務模式的變化。

摘要綜合了來自醫療設備類別、應用領域、終端用戶、分銷管道、技術、交付方式和患者群體等方面的證據，以確定可操作的優先事項。每個章節都重點闡述了對產品開發、商業化和供應鏈韌性的影響。報告著重提供實用見解和建議行動，旨在支持企業在瞬息萬變的呼吸照護領域做出明智的決策，從而增強競爭優勢、加快價值實現速度並降低執行風險。

對影響呼吸設備產品開發和競爭優勢的技術、監管和醫療服務模式變革進行深入評估

人口結構變化、醫療服務模式轉變以及設備技術的快速創新正在顯著改變呼吸治療設備的模式。人口老化和慢性呼吸系統疾病盛行率的上升增加了對呼吸治療設備的需求，同時醫療系統也積極地從住院治療轉向門診治療和居家管理。因此，產品設計優先考慮便攜性、易用性和與遠端監測功能的整合，以提高患者依從性並減少再入院率。

同時，技術進步正在改變主要醫療器材系列的性能和易用性。吸入器採用更有效率的推進劑和粉末輸送機制，霧化器技術正朝著網狀和超音波平台發展，從而提供更安靜的運作和更均勻的氣溶膠顆粒大小。由於能源效率和壓縮技術的進步，氧氣濃縮機正變得更輕、更運作、更可攜式系統。人工呼吸器設計正在整合更智慧的演算法和使用者介面，以支援各種醫療環境下的有創和非侵入性通氣模式。

監管和報銷環境也在影響技術創新的發展軌跡。監管機構日益關注人為因素、網路安全和真實世界證據，而支付方則強調價值、療效以及降低急診使用率的能力。這些因素促使製造商投資於臨床檢驗、互通資料平台和上市後監測框架。因此，設備製造商、軟體供應商和醫療網路營運商之間的合作日益增多，這反映出更廣泛的趨勢，即建立能夠帶來可衡量的臨床和經濟效益的生態系統。

最後，供應鏈韌性已成為一項策略重點。各公司正在實現供應商多元化、生產區域化，並投資於視覺化工具，以應對零件短缺和物流中斷。這些營運措施對於維持產品持續供應和滿足多個醫療機構不斷成長的需求至關重要。總而言之，這些轉變正在重新定義競爭優勢，成功越來越依賴涵蓋工程、監管策略、臨床證據產生和商業性夥伴關係等跨職能能力。

關稅調整對設備價值鏈各環節的採購、生產基地、採購合約和營運韌性的實際影響

2025年，美國關稅政策的調整為全球呼吸治療設備供應商和採購商帶來了新的商業挑戰和策略考量。關稅調整實際上提高了國際採購的關鍵零件和成品的到岸成本，促使製造商重新評估籌資策略和生產地點。進口成本的增加對那些依賴國內不廣泛生產的專用零件的設備影響尤為嚴重，因此，供應商多元化和近岸外包變得更加重要。

這些關稅調整正對醫院、門診中心和大型居家照護服務供應商的採購週期產生連鎖反應，因為供應商會尋求保護利潤率或將增加的成本轉嫁給買家。為此，採購機構擴大在合約中加入彈性價格設定條款、數量承諾加價格保護以及庫存緩衝條款。這些合約調整旨在在貿易政策不確定時期穩定供應和成本風險。

製造商正透過加快區域製造投資和精簡全球供應鏈來應對關稅挑戰，以降低關稅風險。這些策略舉措包括與當地合作夥伴成立合資企業、擴大關稅優惠地區的產能以及提高關鍵零件的垂直整合度。此外，產品團隊正在審查物料材料清單，探索零件替代方案，以減少對關稅敏感的成分，同時保持臨床效能。雖然這些營運調整可能會在生產過渡期間延長產品前置作業時間，但它們也有助於增強應對未來政策變化的能力。

在競爭中，能夠快速重組供應鏈並維持價格穩定的公司將在競標和長期合約談判中佔據優勢。同時，服務供應商和醫療系統在採購決策中必須權衡成本、供應穩定性以及替代設備的臨床療效。總體而言，關稅政策的調整凸顯了製定一套適應性強的商業性策略的必要性，該策略應協調採購、生產和合約簽訂策略，以減輕對下游醫療服務可近性和整體醫療成本的影響。

細分層面的分析揭示了影響設備採用的醫療設備類別分類、醫療環境、分銷管道、技術差距和患者屬性。

細分市場分析揭示了不同設備類別和臨床環境下的細微需求模式和技術優先順序。根據設備類型，市場可分為吸入器、霧化器、氧氣濃縮機和人工呼吸器。其中，吸入器進一步細分為乾粉吸入器、定量吸入器和緩霧吸入器；霧化器分為噴射式霧化器、網式霧化器和超音波霧化器；氧氣濃縮機分為可攜式和固定式；人工呼吸器分為有創式和無創式，前者又細分為壓力控制式呼吸機和容量人工呼吸器。這種細分揭示了工程權衡和使用者偏好之間的差異：便攜性和噪音水平會影響居家照護和醫院環境中設備的採用率，而先進的通氣模式則在重症加護環境中更為重要。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 引入人工智慧人工呼吸器，用於預測性呼吸支援管理
  • 將可攜帶式氧氣設備與遠端醫療平台整合，用於遠端監測
  • 開發一款具備數位化用藥依從性追蹤和雲端分析功能的智慧吸入器
  • 利用患者特定演算法增強居家無創通氣
  • 為分佈式加護治療支持網路引入模組化體外膜氧合（ECMO）系統
  • 將3D列印的患者特異性氣道支架和支氣管植入整合到治療方案中
  • 推出一款結合了超音波霧化器、抗菌過濾器和加濕器的設備
  • 利用穿戴式呼吸監測儀提供即時生物特徵數據，用於慢性阻塞性肺病管理
  • 利用振動網式霧化器進行藥物輸送的進展，可實現高效氣溶膠治療
  • 一次性CPAP面罩的監管核准趨勢側重於患者舒適度

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 按設備類型分類的治療性呼吸設備市場

  • 吸入器
    • 乾粉吸入器
    • 定量噴霧吸入器
    • 緩霧吸入器
  • 噴霧器
    • 噴射式霧化器
    • 網狀霧化器
    • 超音波霧化器
  • 氧氣濃縮機
    • 可攜式的
    • 固定式
  • 人工呼吸器
    • 侵入式人工呼吸器
      • 壓力控制人工呼吸器
      • 容量人工呼吸器
    • 非侵入性人工呼吸器

9. 按應用分類的治療性呼吸設備市場

  • 門診治療
  • 緊急醫療服務
  • 居家照護
  • 醫院

第10章 按最終用戶分類的治療性呼吸設備市場

  • 門診治療中心
  • 緊急服務
  • 居家照護環境
    • 專業居家護理
    • 自我管理
  • 醫院
    • 私立醫院
    • 公立醫院

第11章 按分銷管道分類的治療性呼吸設備市場

  • 醫院採購
  • 線上零售
  • 零售藥局
  • 專科診所

12. 按技術分類的治療性呼吸設備市場

  • 噴射
  • 網狀噴霧
  • 壓力控制輸送
  • 超音波霧化

13. 按模式分類的治療性呼吸設備市場

  • 侵入性
  • 非侵入性

14. 依患者類型分類的治療性呼吸設備市場

  • 成人
  • 老年人
  • 孩子們

15. 按地區分類的治療性呼吸設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 按類別分類的治療性呼吸設備市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 各國治療性呼吸設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Koninklijke Philips NV
    • ResMed Inc.
    • Fisher & Paykel Healthcare Corporation Limited
    • Medtronic plc
    • Dragerwerk AG & Co. KGaA
    • Hamilton Medical AG
    • Nihon Kohden Corporation
    • Vyaire Medical, Inc.
    • Invacare Corporation
    • Nipro Corporation
Product Code: MRR-8C74ADFC179A

The Therapeutic Respiratory Devices Market is projected to grow by USD 70.60 billion at a CAGR of 16.15% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 21.30 billion
Estimated Year [2025] USD 24.68 billion
Forecast Year [2032] USD 70.60 billion
CAGR (%) 16.15%

Comprehensive overview framing the evolving therapeutic respiratory device landscape and strategic priorities for product, clinical, and commercial leaders

This executive summary introduces a comprehensive analysis of therapeutic respiratory devices, examining the structural, technological, and regulatory forces reshaping device development, distribution, and clinical adoption. The objective is to provide senior leaders, strategy teams, and clinical procurement stakeholders with a clear, evidence-based synthesis of critical trends, competitive dynamics, and operational considerations that influence decisions across product portfolios and service lines.

We begin by situating therapeutic respiratory devices within the broader continuum of respiratory care, highlighting the increasing convergence of outpatient and home-based treatment models, the acceleration of digital-enabled device features, and the rising emphasis on patient-centric design. Taken together, these forces are elevating the importance of interoperable systems, user-friendly interfaces, and robust post-market surveillance. In this context, leadership must balance the imperatives of clinical efficacy, cost containment, and regulatory compliance while anticipating shifts in payer expectations and care-delivery pathways.

The summary synthesizes cross-cutting evidence from device categories, applications, end users, distribution channels, technologies, modes of delivery, and patient segments to identify actionable priorities. Each section foregrounds implications for product development, commercialization, and supply chain resilience. By focusing on practical insights and recommended actions, this report aims to support informed decisions that strengthen competitive positioning, accelerate time-to-value, and reduce execution risk in a dynamic therapeutic respiratory landscape.

Detailed assessment of the technological, regulatory, and care-delivery transformations reshaping product development and competitive advantage in respiratory devices

The landscape for therapeutic respiratory devices is undergoing transformative shifts driven by demographic trends, care-delivery migration, and rapid innovation in device technologies. Aging populations and rising prevalence of chronic respiratory conditions are increasing demand, while healthcare systems are actively shifting care from inpatient settings to ambulatory care and home-based management. As a result, product design is prioritizing portability, simplicity of use, and integration with remote monitoring capabilities to support adherence and reduce readmissions.

Concurrently, technological advances are changing the performance and usability profile of core device families. Inhalers are evolving with more efficient propellant and powder delivery mechanisms, and nebulizer technologies are moving toward mesh and ultrasonic platforms that offer quieter operation and more consistent aerosol particle sizes. Oxygen concentrators are seeing advances in energy efficiency and compression technology that enable lighter, longer-running portable systems. Ventilator design is integrating smarter algorithms and user interfaces to support both invasive and noninvasive modes across care settings.

Regulatory and reimbursement environments are also shaping innovation trajectories. Regulators are increasingly focused on human factors, cybersecurity, and real-world evidence, while payers emphasize value, outcomes, and the ability to reduce acute care utilization. These forces incentivize manufacturers to invest in clinical validation, interoperable data platforms, and post-market surveillance frameworks. As a consequence, alliances between device makers, software providers, and care network operators are becoming more prominent, reflecting a broader move toward ecosystems that deliver measurable clinical and economic benefits.

Finally, supply chain resilience has risen as a strategic priority. Firms are diversifying supplier bases, regionalizing production footprints, and investing in visibility tools to manage component shortages and logistic disruptions. These operational responses are essential to maintain continuity in product availability and to meet rising demand across multiple care settings. Taken together, the shifts described here are redefining competitive advantage, where success increasingly depends on cross-functional capabilities spanning engineering, regulatory strategy, clinical evidence generation, and commercial partnerships.

Practical implications of tariff adjustments on sourcing, production footprint, procurement contracts, and operational resilience across device value chains

In 2025, adjustments to United States tariff policies introduced a new set of operational headwinds and strategic considerations for global suppliers and purchasers of therapeutic respiratory devices. Tariff realignment has effectively increased landed costs for key components and finished devices sourced internationally, prompting manufacturers to reevaluate sourcing strategies and production footprints. Increased import costs are particularly acute for devices reliant on specialized components not widely manufactured domestically, which has amplified emphasis on supplier diversification and nearshoring initiatives.

These tariff shifts have had a cascading impact on procurement cycles within hospitals, ambulatory care centers, and large homecare service providers. Contract negotiations now factor in greater price volatility and longer lead times as suppliers seek to protect margins or pass incremental costs to buyers. In response, purchasing organizations are increasingly structuring contracts with flexible pricing clauses, volume commitments tied to price protection, and inventory buffering provisions. These contractual changes aim to stabilize supply and cost exposure during periods of trade policy uncertainty.

Manufacturers are responding by accelerating regional manufacturing investments and rationalizing global supply chains to reduce tariff exposure. Such strategic moves include entering joint ventures with local partners, expanding capacity in tariff-favored jurisdictions, and increasing vertical integration for critical components. Additionally, product teams are reviewing bills of materials and exploring component substitutions that preserve clinical performance while lowering tariff-sensitive content. These operational shifts can yield longer product lead times for new introductions as production transitions occur, but they also build resilience against future policy volatility.

From a competitive standpoint, companies that can reconfigure supply chains rapidly and maintain price stability will gain an advantage in tender processes and long-term contracts. Meanwhile, service providers and health systems must weigh the trade-offs between cost, supply security, and the clinical profile of alternative devices when making procurement decisions. Overall, tariff policy adjustments underscore the necessity for an adaptive commercial playbook that aligns sourcing, manufacturing, and contracting strategies to mitigate downstream impacts on availability and total cost of care.

Segment-level analysis revealing device category distinctions, care settings, distribution channels, technology differentials, and patient demographics influencing adoption

Segmentation analysis reveals nuanced demand patterns and technology priorities across device categories and clinical settings. Based on Device Type, the market is studied across Inhalers, Nebulizers, Oxygen Concentrators, and Ventilators, with Inhalers further differentiated into Dry Powder Inhaler, Metered Dose Inhaler, and Soft Mist Inhaler. Nebulizers are examined across Jet Nebulizer, Mesh Nebulizer, and Ultrasonic Nebulizer, while Oxygen Concentrators are categorized as Portable and Stationary and Ventilators as Invasive and Noninvasive, the former subdivided into Pressure Controlled Ventilator and Volume Controlled Ventilator. This granularity highlights where engineering trade-offs and user preferences diverge, with portability and noise profiles influencing uptake in homecare versus hospital settings, and advanced ventilation modes being prioritized in critical care environments.

Based on Application, the market is studied across Ambulatory Care, Emergency Medical Services, Homecare, and Hospital, which clarifies how device design and service models must align with the operational tempo and clinical requirements of each setting. Based on End User, the market is studied across Ambulatory Care Centers, Emergency Services, Homecare Settings, and Hospitals, with Homecare Settings further split into Professional Homecare and Self Administration and Hospitals further divided into Private Hospitals and Public Hospitals. These distinctions matter for training, warranty models, and after-sales support, since devices intended for self-administration emphasize intuitive interfaces and low-maintenance designs, whereas professional settings demand serviceability and integration with clinical records.

Based on Distribution Channel, the market is studied across Hospital Purchase, Online Retail, Retail Pharmacy, and Specialty Clinics, which informs channel strategy and margins. Based on Technology, the market is studied across Jet Nebulization, Mesh Nebulization, Pressure Controlled Delivery, and Ultrasonic Nebulization, highlighting that technology choice affects clinical performance, maintenance burden, and patient experience. Based on Mode, the market is studied across Invasive and Noninvasive delivery options, and based on Patient Type, the market is studied across Adult, Geriatric, and Pediatric populations. Patient demographics and mode of delivery jointly shape device ergonomics, dosing accuracy, and caregiver training programs. Taken together, segmentation underscores where differentiated product features, evidence generation, and channel partnerships will most effectively meet stakeholder needs.

Regional evaluation of adoption patterns, regulatory nuances, and commercial approaches for Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics affect technology adoption, regulatory pathways, and commercial execution. In the Americas, procurement practices tend to emphasize clinical outcomes, cost-effectiveness, and integration with reimbursement frameworks, encouraging devices that demonstrate measurable reductions in acute care utilization and clear pathways for billing in outpatient and homecare settings. Regulatory alignment and established reimbursement codes support faster adoption cycles for validated solutions, while regional manufacturing capacity in North America can mitigate tariff exposure and shorten lead times.

In Europe, Middle East & Africa, diverse regulatory regimes and healthcare financing models create a spectrum of adoption velocities and value thresholds. Western European markets often prioritize clinical evidence and interoperability, while markets across the Middle East and Africa may emphasize price sensitivity and durability under variable infrastructure conditions. Consequently, manufacturers benefit from tailored market entry strategies that adapt device configuration, service offerings, and pricing to local healthcare system capabilities and procurement norms.

In Asia-Pacific, rapid urbanization, expanding private healthcare provision, and growing homecare demand are driving significant uptake of portable and digitally enabled respiratory devices. Regulatory agencies across the region are increasingly harmonizing standards, and local manufacturing ecosystems are expanding, enabling faster commercialization when regulatory and clinical prerequisites are aligned. Across all regions, partnerships with local distributors, adaptation to regional clinical pathways, and investment in regional training and service networks are essential to achieving sustained market traction and to support long-term device performance in varied care environments.

Competitive landscape analysis emphasizing strategic partnerships, clinical differentiation, and operational excellence as primary levers of market leadership

Competitive dynamics are shaped by the interplay of legacy device incumbents, agile medical technology challengers, and new entrants leveraging software and connected-device capabilities. Established manufacturers often compete on scale, regulatory experience, and integrated service networks, which supports deep penetration in institutional channels and long-term service contracts. At the same time, smaller and mid-sized companies are gaining traction through niche innovation, faster product iteration cycles, and targeted clinical evidence programs that demonstrate differentiation on usability, therapy adherence, or cost of care reduction.

Collaboration between device firms and digital health vendors is accelerating, with partnerships focused on remote monitoring, adherence support, and data-driven outcomes measurement. These collaborations create new value propositions for payers and providers by linking device performance to patient outcomes. In parallel, distributors and specialty clinic networks are adapting their portfolios to include a broader range of portable and homecare-focused devices, reshaping route-to-market strategies and after-sales service models.

Mergers, acquisitions, and strategic alliances remain active avenues for capability expansion, enabling parties to combine clinical expertise, regulatory know-how, and geographic reach. Firms that invest in robust clinical programs, human factors engineering, and scalable post-market support differentiate themselves in procurement processes. Operational excellence in manufacturing, quality systems, and supply chain management also contributes materially to competitive positioning, particularly in environments where reliability and uptime are mission-critical for care delivery.

Actionable strategic roadmap for manufacturers and providers to optimize product design, supply chains, clinical evidence, and channel strategies for sustained growth

Industry leaders should prioritize a set of integrated actions to strengthen resilience, capture clinical value, and accelerate adoption across care settings. First, align product roadmaps with use-case driven design by emphasizing portability, intuitive interfaces, and interoperability with electronic health records and remote monitoring platforms. Prioritizing human factors testing and real-world usability studies will reduce adoption friction and support payer conversations about outcomes.

Second, de-risk supply chains by diversifying suppliers, increasing regional manufacturing capacity where feasible, and building inventory strategies that balance cost with continuity. Embedding tariff-sensitivity assessments into sourcing decisions and creating contractual mechanisms for price protection can reduce exposure to trade-policy volatility. Concurrently, streamline bills of materials to minimize reliance on single-source, tariff-exposed components without sacrificing clinical performance.

Third, invest in clinical evidence and health-economic dossiers that demonstrate value across institutional and homecare settings. Clinical partnerships that enable pragmatic studies and post-market evidence collection will enhance reimbursement discussions and procurement evaluations. Fourth, develop channel-specific commercial models that reflect the needs of hospital procurement teams, specialty clinics, retail pharmacy networks, and online retail, ensuring that service and warranty offerings are tailored to how end users will operate the devices.

Finally, pursue strategic collaborations with digital health vendors, payers, and care networks to create bundled solutions that tie device performance to outcomes and cost-of-care improvements. These partnerships can facilitate pilot programs, accelerate payer acceptance, and open pathways to value-based contracting. Taken together, these actions position companies to compete on both clinical merit and commercial relevance.

Transparent mixed-methods research approach combining primary stakeholder interviews, regulatory and clinical literature review, and operational case analysis to support practical insights

This research synthesizes primary interviews with clinical leaders, procurement specialists, device engineers, and regulatory experts, combined with a structured review of recent regulatory guidance, device approvals, and publicly reported company initiatives. Primary qualitative engagements were conducted to surface practitioner perspectives on device usability, clinical performance priorities, and procurement decision drivers. These interviews informed the interpretive framework used across device types, applications, and end-user segments.

Secondary research included a targeted analysis of peer-reviewed clinical literature, regulatory documentation, and patent filings to validate technology trends and to assess the maturity of nebulization, inhalation, oxygen concentration, and ventilation platforms. Operational and supply-chain insights were derived from case studies, manufacturing disclosures, and industry reports, enabling a realistic appraisal of production constraints and sourcing risks. Wherever possible, triangulation was used to corroborate findings across multiple sources and perspectives.

The methodological approach emphasizes transparency in assumptions and a conservative stance on inference when primary or secondary data were limited. Analysis prioritized actionable implications over speculative projections and explicitly linked evidence to recommended actions. Limitations include the evolving nature of trade policy and regional regulatory harmonization, which may change the operational context; the report flags these as areas for ongoing monitoring and rapid reassessment.

Concluding synthesis emphasizing the imperative of integrated product, evidence, and operational strategies to navigate evolving clinical and policy environments

In conclusion, therapeutic respiratory device stakeholders face a period of meaningful change driven by technological evolution, care-delivery migration, and policy shifts that affect sourcing and procurement. Success will depend on the ability to integrate human-centered design, robust clinical evidence, and flexible manufacturing and distribution strategies. Organizations that proactively address tariff-related risks, invest in interoperable digital capabilities, and tailor commercial approaches to segmented care pathways will secure stronger positioning as the landscape evolves.

Decision-makers should treat the insights in this summary as a strategic foundation for targeted investments in product development, evidence generation, and supply chain resilience. By coupling operational discipline with an outcomes-oriented commercial narrative, firms can translate technical advantages into measurable value for providers, payers, and patients. The coming period will reward pragmatic execution that aligns innovation with demonstrable clinical and economic improvements.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of AI-enabled ventilators for predictive respiratory support management
  • 5.2. Integration of telehealth platforms with portable oxygen concentrators for remote monitoring
  • 5.3. Development of smart inhalers with digital adherence tracking and cloud analytics
  • 5.4. Expansion of home-based noninvasive ventilation devices with patient-specific algorithms
  • 5.5. Emergence of modular ECMO systems for decentralized intensive care support networks
  • 5.6. Incorporation of 3D-printed patient-specific airway stents and bronchial implants
  • 5.7. Launch of combined ultrasonic nebulizer and humidifier devices with antimicrobial filters
  • 5.8. Use of wearable respiratory monitors providing real-time biometric data for COPD management
  • 5.9. Advances in drug delivery through vibrating mesh nebulizers for efficient aerosol therapy
  • 5.10. Regulatory approval trends for disposable CPAP masks focused on enhanced patient comfort

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Therapeutic Respiratory Devices Market, by Device Type

  • 8.1. Inhalers
    • 8.1.1. Dry Powder Inhaler
    • 8.1.2. Metered Dose Inhaler
    • 8.1.3. Soft Mist Inhaler
  • 8.2. Nebulizers
    • 8.2.1. Jet Nebulizer
    • 8.2.2. Mesh Nebulizer
    • 8.2.3. Ultrasonic Nebulizer
  • 8.3. Oxygen Concentrators
    • 8.3.1. Portable
    • 8.3.2. Stationary
  • 8.4. Ventilators
    • 8.4.1. Invasive Ventilators
      • 8.4.1.1. Pressure Controlled Ventilator
      • 8.4.1.2. Volume Controlled Ventilator
    • 8.4.2. Noninvasive Ventilators

9. Therapeutic Respiratory Devices Market, by Application

  • 9.1. Ambulatory Care
  • 9.2. Emergency Medical Services
  • 9.3. Homecare
  • 9.4. Hospital

10. Therapeutic Respiratory Devices Market, by End User

  • 10.1. Ambulatory Care Centers
  • 10.2. Emergency Services
  • 10.3. Homecare Settings
    • 10.3.1. Professional Homecare
    • 10.3.2. Self Administration
  • 10.4. Hospitals
    • 10.4.1. Private Hospitals
    • 10.4.2. Public Hospitals

11. Therapeutic Respiratory Devices Market, by Distribution Channel

  • 11.1. Hospital Purchase
  • 11.2. Online Retail
  • 11.3. Retail Pharmacy
  • 11.4. Specialty Clinics

12. Therapeutic Respiratory Devices Market, by Technology

  • 12.1. Jet Nebulization
  • 12.2. Mesh Nebulization
  • 12.3. Pressure Controlled Delivery
  • 12.4. Ultrasonic Nebulization

13. Therapeutic Respiratory Devices Market, by Mode

  • 13.1. Invasive
  • 13.2. Noninvasive

14. Therapeutic Respiratory Devices Market, by Patient Type

  • 14.1. Adult
  • 14.2. Geriatric
  • 14.3. Pediatric

15. Therapeutic Respiratory Devices Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Therapeutic Respiratory Devices Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Therapeutic Respiratory Devices Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. Koninklijke Philips N.V.
    • 18.3.2. ResMed Inc.
    • 18.3.3. Fisher & Paykel Healthcare Corporation Limited
    • 18.3.4. Medtronic plc
    • 18.3.5. Dragerwerk AG & Co. KGaA
    • 18.3.6. Hamilton Medical AG
    • 18.3.7. Nihon Kohden Corporation
    • 18.3.8. Vyaire Medical, Inc.
    • 18.3.9. Invacare Corporation
    • 18.3.10. Nipro Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. THERAPEUTIC RESPIRATORY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. THERAPEUTIC RESPIRATORY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. THERAPEUTIC RESPIRATORY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED DOSE INHALER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SOFT MIST INHALER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SOFT MIST INHALER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SOFT MIST INHALER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SOFT MIST INHALER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SOFT MIST INHALER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SOFT MIST INHALER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE VENTILATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED VENTILATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROLLED VENTILATOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE VENTILATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE VENTILATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE VENTILATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE VENTILATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE VENTILATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE VENTILATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PROFESSIONAL HOMECARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PROFESSIONAL HOMECARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PROFESSIONAL HOMECARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PROFESSIONAL HOMECARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PROFESSIONAL HOMECARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PROFESSIONAL HOMECARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SELF ADMINISTRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SELF ADMINISTRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SELF ADMINISTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SELF ADMINISTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROLLED DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GERIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2025